Target intelligence / Profile preview

RNA, U1 small nuclear 67, pseudogene (RNU1-67P)

Target: RNU1-67P
Molecular classification: Non-coding RNA, Pseudogene

Overview

RNU1-67P (RNA, U1 small nuclear 67, pseudogene) encodes a non-coding RNA pseudogene sequence homologous to the canonical U1 small nuclear RNA gene. U1 snRNA is an essential component of the spliceosome, required for pre-mRNA splicing and transcriptome integrity. RNU1-67P itself does not produce functional snRNA or protein and is classified as a pseudogene. Some U1 pseudogenes in the same family can be transcribed and appear to play nuanced regulatory roles in cell fate or RNA processing, but there is no direct evidence that RNU1-67P is among the functionally active variants. Its function, if any, remains unknown, and it is not currently relevant as a therapeutic target or biomarker.

Other names: RNA, U1 small nuclear 67, pseudogeneRNU1-67P

Mechanism of action

Not applicable; there are no drugs targeting RNU1-67P.

Biological functions

There is currently no evidence for a protein-coding or direct functional role for RNU1-67P. For the broader family of U1 pseudogenes (of which RNU1-67P is a member), emerging data suggest some pseudogenes may produce variant snRNAs that participate in pre-mRNA processing or may have regulatory functions in gene expression. However, these findings are specific to some variant pseudogenes, and it is unknown if RNU1-67P itself is transcribed or functional.

Disease associations

None specifically attributed to RNU1-67P. For related variant U1 snRNAs, differential expression has been observed in cancer cell lines and stem cells, but RNU1-67P itself is not implicated in any disease roles to date.

Safety considerations

None reported. As a pseudogene, it is not a candidate for pharmacological targeting.

Interacting drugs

None known or reported for RNU1-67P, as it is not a recognized therapeutic target.

Biomarkers

None known or reported for patient selection or efficacy monitoring involving RNU1-67P.

Beyond the preview

Go deeper on RNA, U1 small nuclear 67, pseudogene (RNU1-67P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 67, pseudogene (RNU1-67P).

Explore the full profile